Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11858980 Engineered polypeptides and uses thereof

Patent 11858980 was granted and assigned to Visterra Inc. on January, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 4 Jan, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 4 Jan, 2024
Edits made to:
Infobox (+62 properties)
Article (+191 characters)
‌

 US Patent 11858980 Engineered polypeptides and uses thereof

Article

Patent abstract

Polypeptides, such as antibody molecules and fusion proteins, comprising an Fc region, are disclosed. The polypeptides can be used to treat, prevent, and/or diagnose disorders.

Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
Visterra Inc.
0
Current Assignee
‌
Visterra Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118589800
Patent Inventor Names
Andrew M. Wollacott0
Boopathy Ramakrishnan0
Brian Booth0
Karthik Viswanathan0
Kristin Narayan0
Date of Patent
January 2, 2024
0
Patent Application Number
156673090
Date Filed
August 2, 2017
0
Patent Citations
‌
US Patent 7122637 Polypeptide variants with altered effector function
0
‌
US Patent 7183387 Polypeptide variants with altered effector function
0
‌
US Patent 7332581 Polypeptide variants with altered effector function
0
‌
US Patent 7335742 Polypeptide variants with altered effector function
0
‌
US Patent 7355008 Identification and engineering of antibodies with variant Fc regions and methods of using same
0
‌
US Patent 7371826 Polypeptide variants with altered effector function
0
‌
US Patent 7416727 Polypeptide variants with altered effector function
0
‌
US Patent 7658921 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 7670600 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 7704497 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 7785791 Polypeptide variants with altered effector function
0
‌
US Patent 7790858 Polypeptide variants with altered effector function
0
‌
US Patent 8003774 Identification and engineering of antibodies with variant Fc regions and methods of using same
0
‌
US Patent 8012476 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 8088376 Fc variants with altered binding to FcRn
0
‌
US Patent 8124731 Optimized Fc variants and methods for their generation
0
‌
US Patent 8163882 Polypeptide variants with altered effector function
0
‌
US Patent 8192737 Identification and engineering of antibodies with variant Fc regions and methods of using same
0
‌
US Patent 8318907 Fc variants with altered binding to FcRn
0
‌
US Patent 8323962 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 8324351 Fc variants with altered binding to FcRn
0
‌
US Patent 8338574 FC variants with altered binding to FCRN
0
‌
US Patent 8367805 Fc variants with altered binding to FcRn
0
‌
US Patent 8394925 Fc variants with altered binding to FcRn
0
‌
US Patent 8475792 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 8546543 Fc variants that extend antibody half-life
0
‌
US Patent 8618251 Fc mutants
0
‌
US Patent 8674083 Polypeptide variants with altered effector function
0
‌
US Patent 8734791 Optimized fc variants and methods for their generation
0
‌
US Patent 8742074 Optimized FC variants
0
‌
US Patent 8795661 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 8802820 Fc variants with altered binding to FcRn
0
‌
US Patent 8852586 Fc variants with altered binding to FcRn
0
‌
US Patent 8883973 Fc variants with altered binding to FcRn
0
‌
US Patent 8952132 Engineered immunoglobulin FC polypeptides
0
‌
US Patent 8969526 Antibody Fc variants
0
‌
US Patent 9028815 Identification and engineering of antibodies with variant FC regions and methods of using same
0
‌
US Patent 9200079 Fc variants with altered binding to FcRn
0
‌
US Patent RE45992 Optimized FC variants
0
‌
US Patent 9562100 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 9771426 Engineered immunoglobulin FC polypeptides
0
‌
US Patent RE46585 Optimized FC variants
0
‌
US Patent 9803023 Fc variants with altered binding to FcRn
0
‌
US Patent 10011660 Molecules with reduced effector function and extended half-lives, compositions, and uses thereof
0
‌
US Patent 10253100 Therapeutic antigen-binding molecule with a FcRn-binding domain that promotes antigen clearance
0
‌
US Patent 10336818 Fc variants with altered binding to FcRn
0
‌
US Patent 10556949 Antigen-binding molecule inducing immune response to target antigen
0
‌
US Patent 7083784 Molecules with extended half-lives, compositions and uses thereof
0
Patent Primary Examiner
‌
Chun W Dahle
0

Find more entities like US Patent 11858980 Engineered polypeptides and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo